Viral vs. non-viral: The debate
At a packed out session at last week's Controlled Release Society meeting in the US, two experts battled it out to win one of the key debates in gene delivery: which is superior - viral or non-viral delivery?
At a packed out session at last week's Controlled Release Society meeting in the US, two experts battled it out to win one of the key debates in gene delivery: which is superior - viral or non-viral delivery?
Australian drug delivery specialist Acrux has reported positive results in Phase II trials of its innovative under-arm lotion formulation for testosterone replacement therapy.
Biocon is targeting the global cell culture market with the production of pharmaceutical-grade insulin as a potent growth factor.
Canadians finally have access to the controlled-release formulation of naproxen sodium, which has been on the US market for more than 10 years for the management of osteoarthritis and rheumatoid arthritis.
Integrated DNA Technologies (IDT) has launched a new kit for cloning libraries of small RNAs from any primary RNA source to enable the discovery of new small RNA molecules.